• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Philadelphia-positive (PH+) acute lymphoblastic leukemia (ALL): developing strategies for curing this stubborn disease.

作者信息

Liam Christopher Chin Keong, Boo Yang Liang, Chong Siew Lian, Sathar Jameela, Ong Tee Chuan, Tan Sen Mui

机构信息

Department of Haematology, Hospital Ampang, Selangor, Malaysia.

Hematology Unit, Department of Internal Medicine, Hospital Sultanah Aminah, Johor, Malaysia.

出版信息

Blood Res. 2022 Jun 30;57(2):158-161. doi: 10.5045/br.2022.2020305. Epub 2022 May 30.

DOI:10.5045/br.2022.2020305
PMID:35620904
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9242836/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb92/9242836/d231e5b1de27/br-57-2-158-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb92/9242836/d231e5b1de27/br-57-2-158-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb92/9242836/d231e5b1de27/br-57-2-158-f1.jpg

相似文献

1
Philadelphia-positive (PH+) acute lymphoblastic leukemia (ALL): developing strategies for curing this stubborn disease.
Blood Res. 2022 Jun 30;57(2):158-161. doi: 10.5045/br.2022.2020305. Epub 2022 May 30.
2
Philadelphia chromosome positive pre-T cell acute lymphoblastic leukemia: a rare case report and short review.费城染色体阳性前体T细胞急性淋巴细胞白血病：一例罕见病例报告及简要综述
Indian J Hematol Blood Transfus. 2014 Sep;30(Suppl 1):177-9. doi: 10.1007/s12288-013-0314-8. Epub 2014 Jan 22.
3
P190 in a Patient with Philadelphia Chromosome Positive T-Cell Acute Lymphoblastic Leukemia: A Rare Case Report and Review of Literature.费城染色体阳性T细胞急性淋巴细胞白血病患者中的P190：一例罕见病例报告及文献复习
Case Rep Oncol. 2021 Jul 1;14(2):1040-1050. doi: 10.1159/000516270. eCollection 2021 May-Aug.
4
Philadelphia chromosome negative acute lymphoblastic leukemia preceding Philadelphia positive chronic myelogenous leukemia.
Cancer Genet Cytogenet. 1989 Jun;39(2):147-52. doi: 10.1016/0165-4608(89)90179-9.
5
A case of Philadelphia chromosome positive acute lymphoblastic leukemia with partial trisomy of chromosome 1q involving chromosome 13 as the acceptor-A novel cytogenetic finding.1例费城染色体阳性急性淋巴细胞白血病伴1q部分三体，涉及13号染色体作为受体——一项新的细胞遗传学发现
Pathol Res Pract. 2017 Jan;213(1):72-74. doi: 10.1016/j.prp.2016.08.016. Epub 2016 Sep 4.
6
Dasatinib-induced complete molecular response after allogeneic hematopoietic stem cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia resistant to prior imatinib-containing regimen: a case report and discussion.达沙替尼诱导费城染色体阳性急性淋巴细胞白血病对既往含伊马替尼方案耐药患者异基因造血干细胞移植后完全分子缓解：1 例病例报告并讨论
Med Oncol. 2010 Dec;27(4):1123-6. doi: 10.1007/s12032-009-9347-0. Epub 2009 Nov 3.
7
Outcome of patients with chronic myeloid leukemia in lymphoid blastic phase and Philadelphia chromosome-positive acute lymphoblastic leukemia treated with hyper-CVAD and dasatinib.接受 Hyper-CVAD 和达沙替尼治疗的慢性髓性白血病伴淋巴母细胞样变期和费城染色体阳性急性淋巴细胞白血病患者的结局。
Cancer. 2021 Aug 1;127(15):2641-2647. doi: 10.1002/cncr.33539. Epub 2021 Apr 6.
8
miR-451a induced apoptosis of Philadelphia chromosome-positive acute lymphoblastic leukemia cells by targeting IL-6R.miR-451a 通过靶向 IL-6R 诱导费城染色体阳性急性淋巴细胞白血病细胞凋亡。
Neoplasma. 2018 Nov 15;65(6):907-914. doi: 10.4149/neo_2018_180121N44. Epub 2018 Sep 4.
9
Acute lymphoblastic leukemia without the Philadelphia chromosome occurring in chronic myelogenous leukemia with the Philadelphia chromosome.伴有费城染色体的慢性髓性白血病中出现的无费城染色体的急性淋巴细胞白血病。
Am J Hematol. 2003 Nov;74(3):218-20. doi: 10.1002/ajh.10409.
10
Predictive value of minimal residual disease in Philadelphia-chromosome-positive acute lymphoblastic leukemia treated with imatinib in the European intergroup study of post-induction treatment of Philadelphia-chromosome-positive acute lymphoblastic leukemia, based on immunoglobulin/T-cell receptor and BCR/ABL1 methodologies.基于免疫球蛋白/T 细胞受体和 BCR/ABL1 方法学，伊马替尼治疗后基于微小残留病灶预测费城染色体阳性急性淋巴细胞白血病的欧洲研究组的诱导治疗后治疗的费城染色体阳性急性淋巴细胞白血病的预测价值。
Haematologica. 2018 Jan;103(1):107-115. doi: 10.3324/haematol.2017.176917. Epub 2017 Oct 27.

引用本文的文献

1
Outcome of second allogeneic hematopoietic cell transplantation in adult patients with relapsed B-cell acute lymphoblastic leukemia in the era of new immunotherapeutic agents.新型免疫治疗药物时代成年复发B细胞急性淋巴细胞白血病患者第二次异基因造血细胞移植的结局
Bone Marrow Transplant. 2025 Jun 17. doi: 10.1038/s41409-025-02639-6.
2
Diagnostic and therapeutic advances in adults with acute lymphoblastic leukemia in the era of gene analysis and targeted immunotherapy.基因分析和靶向免疫治疗时代成人急性淋巴细胞白血病的诊断和治疗进展。
Korean J Intern Med. 2024 Jan;39(1):34-56. doi: 10.3904/kjim.2023.407. Epub 2024 Jan 1.

本文引用的文献

1
Dasatinib-Blinatumomab for Ph-Positive Acute Lymphoblastic Leukemia in Adults.达沙替尼联合博纳吐单抗治疗成人费城染色体阳性急性淋巴细胞白血病。
N Engl J Med. 2020 Oct 22;383(17):1613-1623. doi: 10.1056/NEJMoa2016272.
2
Combination of hyper-CVAD with ponatinib as first-line therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia: long-term follow-up of a single-centre, phase 2 study.Hyper-CVAD与波纳替尼联合作为费城染色体阳性急性淋巴细胞白血病患者的一线治疗：一项单中心2期研究的长期随访
Lancet Haematol. 2018 Dec;5(12):e618-e627. doi: 10.1016/S2352-3026(18)30176-5.
3
Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia.
急性淋巴细胞白血病中CD19嵌合抗原受体疗法的长期随访
N Engl J Med. 2018 Feb 1;378(5):449-459. doi: 10.1056/NEJMoa1709919.
4
Complete Hematologic and Molecular Response in Adult Patients With Relapsed/Refractory Philadelphia Chromosome-Positive B-Precursor Acute Lymphoblastic Leukemia Following Treatment With Blinatumomab: Results From a Phase II, Single-Arm, Multicenter Study.费城染色体阳性 B 系前体急性淋巴细胞白血病成年患者经blinatumomab 治疗后的完全血液学和分子学缓解：来自 II 期、单臂、多中心研究的结果。
J Clin Oncol. 2017 Jun 1;35(16):1795-1802. doi: 10.1200/JCO.2016.69.3531. Epub 2017 Mar 29.
5
Use of tyrosine kinase inhibitors to prevent relapse after allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: A position statement of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.酪氨酸激酶抑制剂在费城染色体阳性急性淋巴细胞白血病患者异基因造血干细胞移植后预防复发中的应用：欧洲血液和骨髓移植学会急性白血病工作组的立场声明。
Cancer. 2016 Oct;122(19):2941-51. doi: 10.1002/cncr.30130. Epub 2016 Jun 16.
6
Inotuzumab Ozogamicin versus Standard Therapy for Acute Lymphoblastic Leukemia.奥英妥珠单抗对比标准疗法治疗急性淋巴细胞白血病
N Engl J Med. 2016 Aug 25;375(8):740-53. doi: 10.1056/NEJMoa1509277. Epub 2016 Jun 12.
7
Dasatinib and low-intensity chemotherapy in elderly patients with Philadelphia chromosome-positive ALL.达沙替尼与低强度化疗用于老年费城染色体阳性急性淋巴细胞白血病患者的治疗
Blood. 2016 Aug 11;128(6):774-82. doi: 10.1182/blood-2016-02-700153. Epub 2016 Apr 27.
8
Randomized study of reduced-intensity chemotherapy combined with imatinib in adults with Ph-positive acute lymphoblastic leukemia.Ph 阳性急性淋巴细胞白血病成人患者中采用减低强度化疗联合伊马替尼的随机研究。
Blood. 2015 Jun 11;125(24):3711-9. doi: 10.1182/blood-2015-02-627935. Epub 2015 Apr 15.
9
UKALLXII/ECOG2993: addition of imatinib to a standard treatment regimen enhances long-term outcomes in Philadelphia positive acute lymphoblastic leukemia.UKALLXII/ECOG2993：伊马替尼联合标准治疗方案可改善费城染色体阳性急性淋巴细胞白血病的长期预后。
Blood. 2014 Feb 6;123(6):843-50. doi: 10.1182/blood-2013-09-529008. Epub 2013 Nov 25.
10
Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial.核型是成人急性淋巴细胞白血病（ALL）的一个独立预后因素：对英国医学研究委员会（MRC）UKALLXII/东部肿瘤协作组（ECOG）2993试验中患者的细胞遗传学数据进行分析。
Blood. 2007 Apr 15;109(8):3189-97. doi: 10.1182/blood-2006-10-051912. Epub 2006 Dec 14.